Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$995,308
+$26,348 QoQ
Shares Held
3,919
-1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#3,028
of 4,676 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWS Financial Advisors, LLC holds $4,559,279 across 7 Drug Manufacturers - General names. JNJ ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,387 | $1,103,944 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
3,919 | $995,308 | |
| 3 | LLY |
ELI LILLY & Co
|
705 | $845,598 | |
| 4 | AMGN |
Amgen Inc
|
1,490 | $539,558 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,162 | $399,487 | |
| 6 | PFE |
Pfizer Inc
|
14,856 | $357,732 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,472 | $317,652 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $995,308 | 3,919 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $968,960 | 3,964 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $820,142 | 3,963 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $644,519 | 3,476 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $585,490 | 3,833 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $635,001 | 3,829 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $553,171 | 3,825 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $620,527 | 3,829 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $561,692 | 3,843 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $609,031 | 3,850 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,190,126 | 7,593 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,113,456 | 7,149 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,289,400 | 7,790 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,087,635 | 7,017 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,311,272 | 7,423 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,178,642 | 7,215 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,280,557 | 7,214 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,278,359 | 7,213 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,265,575 | 7,398 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $1,192,717 | 7,240 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $1,219,970 | 7,423 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,166,972 | 7,415 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,080,571 | 7,258 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,057,678 | 7,521 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $934,170 | 7,124 | Shares | Sole | 2020-04-02 | |
| No filing history on record for this holder in this stock. | ||||||